ANGO vs MCO · rev $292.5M vs P/E 33, rev $7.72B
AngioDynamics Inc (ANGO) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported MCO revenue for 2025-12-31 was $7.72B. Net income was $2.46B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
ANGO currently screens at market cap $378.5M. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the ANGO and MCO stock pages for the full models.
Not investment advice.